Abbe Muller
Biographic Data
| ID | 7446785 |
|---|---|
| NAME | Abbe Muller |
| GIVEN NAMES | Abbe |
| FAMILY NAME | Muller |
| SIGNATURE | MULLER A |
| AFFILIATIONS | Yale University |
| ORCID | 0000-0002-2650-8318 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya
Hepatitis C (HCV) disproportionately affects people who inject drugs (PWID). Despite availability of safe and effective treatment, HCV treatment access and uptake among PWID in low- and middle-income countries (LMICs) has been limited. Understanding the lived experiences of PWID in these settings who have undergone treatment provides the opportunity to gain insight into how to implement treatment programs that meet the needs of this population. U…
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Impact of Covid-19 on substance use disorder treatment services in Kenya
Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
Despite disproportionately high rates of Hepatitis C (HCV) among people who inject drugs (PWID) in low- and middle-income countries (LMICs), understanding of HCV-related knowledge, attitudes and perceived risk behaviours among this population remains limited. We aimed to elucidate knowledge, attitudes and experiences that could minimise transmission risk and maximise HCV treatment engagement among PWID in Kenya following the integration of HCV sc…
No prominent works on this page.
Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
Despite disproportionately high rates of Hepatitis C (HCV) among people who inject drugs (PWID) in low- and middle-income countries (LMICs), understanding of HCV-related knowledge, attitudes and perceived risk behaviours among this population remains limited. We aimed to elucidate knowledge, attitudes and experiences that could minimise transmission risk and maximise HCV treatment engagement among PWID in Kenya following the integration of HCV sc…
Impact of Covid-19 on substance use disorder treatment services in Kenya
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya
Hepatitis C (HCV) disproportionately affects people who inject drugs (PWID). Despite availability of safe and effective treatment, HCV treatment access and uptake among PWID in low- and middle-income countries (LMICs) has been limited. Understanding the lived experiences of PWID in these settings who have undergone treatment provides the opportunity to gain insight into how to implement treatment programs that meet the needs of this population. U…
HIV, Drug Use, Sexual Risk (4 works) · Medicine (4 works) · Hepatitis B Virus Studies (3 works) · Hepatitis C (3 works) · Hepatitis C virus research (3 works) · Qualitative research (3 works) · Environmental health (2 works) · Family medicine (2 works) · Nursing (2 works) · Sociology (2 works)